ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 127 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.98 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $497,000 | +328.4% | 340,092 | +315.2% | 0.16% | +419.4% |
| Q4 2016 | $116,000 | -89.1% | 81,909 | -86.6% | 0.03% | -87.8% |
| Q3 2016 | $1,067,000 | +180.1% | 609,929 | +173.8% | 0.26% | +264.3% |
| Q2 2016 | $381,000 | +605.6% | 222,736 | +705.8% | 0.07% | +775.0% |
| Q1 2016 | $54,000 | +28.6% | 27,642 | +25.9% | 0.01% | +100.0% |
| Q3 2015 | $42,000 | -92.5% | 21,950 | -86.4% | 0.00% | -92.6% |
| Q4 2014 | $561,000 | – | 161,682 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 867,700 | $3,636,000 | 1.05% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,847,999 | $24,503,000 | 0.89% |
| MANGROVE PARTNERS IM, LLC | 210,900 | $884,000 | 0.26% |
| Lyons Wealth Management, LLC. | 56,775 | $238,000 | 0.25% |
| Callan Capital, LLC | 76,118 | $319,000 | 0.09% |
| SABBY MANAGEMENT, LLC | 274,782 | $1,151,000 | 0.04% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 338,703 | $1,420,000 | 0.04% |
| WELLINGTON MANAGEMENT GROUP LLP | 29,627,959 | $124,141,000 | 0.03% |
| Cambridge Investment Research Advisors, Inc. | 268,118 | $1,123,000 | 0.03% |
| OppenheimerFunds, Inc. | 7,000,000 | $29,330,000 | 0.03% |